Dabigatran: laboratory monitoring

被引：8

作者：

Jones, Simon D. F. ^{[1
]}

Eaddy, Nicola S. ^{[1
]}

Chan, George T. C. ^{[1
]}

机构：

[1] Auckland City Hosp, Labplus, Dept Haematol, Auckland, New Zealand

来源：

PATHOLOGY | 2012年 / 44卷 / 06期

关键词：

D O I：

10.1097/PAT.0b013e32835833f4

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

[No abstract available]

引用

页码：578 / 580

页数：3

共 6 条

[1] Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against? [J].

Favaloro, Emmanuel J. ;

Lippi, Giuseppe .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (05) :755-757

[2]

Hyphen Biomed, 2010, CK002L HYPH BIOM

[3] Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays [J].

Lindahl, Tomas L. ;

Baghaei, Fariba ;

Blixter, Inger Fagerberg ;

Gustafsson, Kerstin M. ;

Stigendal, Lennart ;

Sten-Linder, Margareta ;

Strandberg, Karin ;

Hillarp, Andreas .

THROMBOSIS AND HAEMOSTASIS, 2011, 105 (02) :371-378

[4] Monitoring direct thrombin inhibitors with a plasma diluted thrombin time [J].

Love, Jason E. ;

Ferrell, Chris ;

Chandler, Wayne L. .

THROMBOSIS AND HAEMOSTASIS, 2007, 98 (01) :234-242

[5] Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity [J].

van Ryn, Joanne ;

Stangier, Joachim ;

Haertter, Sebastian ;

Liesenfeld, Karl-Heinz ;

Wienen, Wolfgang ;

Feuring, Martin ;

Clemens, Andreas .

THROMBOSIS AND HAEMOSTASIS, 2010, 103 (06) :1116-1127

[6]

Weigel G, 2011, GES THROMB HAM GTH W

← 1 →